The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration

Journal of Innate Immunity

Volumn 4, Issue 1, 2011, Pages 41-58

  Berthelot, Florence ^a   Fattoum, Lakhdar ^a   Casulli, Sarah ^a   Gozlan, Joël ^a   Maréchal, Vincent ^a   Elbim, Carole ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Alarmine; Chemotaxis; Inflammation; Neutrophils

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CHEMOTAXIS, LEUKOCYTE; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INTERLEUKIN-8; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 83555164919     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000328798     Document Type: Article

References (43)

1. Babior BM: Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64: 959-966. (Pubitemid 15212033)
2. Bokoch GM: Chemoattractant signaling and leukocyte activation. Blood 1995; 86: 1649-1660.
3. Bianchi ME, Manfredi AA: High mobility group box 1 (HMGB1) protein at the crossroads between native and adaptive immunity. Immunol Rev 2007; 220: 35-46. (Pubitemid 350045574)
4. Sha Y, Zmijewski J, Xu Z, Abraham E: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008; 180: 2531-2537.
5. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Peter A, Kiener PA, Coyle AJ: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-496. (Pubitemid 46605917)
6. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS: High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-production in human monocytes. J Immunol 2008; 180: 5067-5074.
7. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301. (Pubitemid 38084244)
8. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T: A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 2007; 26: 1129-1139.
9. Kuijpers TW, Tool ATJ, Van der Schoot CE, Ginsel LA, Onderwater JJM, Roos D, Verhoeven AJ: Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78: 1105-1111.
10. Jaouen S, de Koning L, Gaillard C, Muselikova-Polanska E, Stros M, Strauss F: Determinants of specific binding of HMGB1 protein to hemicatenated DNA loops. J Mol Biol 2005; 353: 822-837. (Pubitemid 41460542)
11. Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F, Maréchal V: Highmobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS 2007; 21: 283-292. (Pubitemid 46175041)
12. Gaillard C, Borde C, Gozlan J, Maréchal V, Strauss F: A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS ONE 2008; 3:e2855.
13. Palumbo R, De Marchis F, Pusterla T, Conti A, Alessio M, Bianchi ME: Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol 2009; 86: 617-623.
14. Elbim C, Monceaux V, Mueller YM, Lewis MG, François S, Diop O, Akarid K, Hurtrel B, Gougerot-Pocidalo MA, Levy Y, Katsikis PD, Estaquier J: Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic SIV infections of non-human primates. J Immunol 2008; 181: 8613-8623.
15. François S, El Benna J, Dang PMC, Pedruzzi E, Gougerot-Pocidalo MA, Elbim C: Inhibition of neutrophil apoptosis by Toll-like receptor agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-B signaling pathways leading to increased levels of Mcl-1, A1 and phosphorylated Bad. J Immunol 2005; 174: 3633-3642. (Pubitemid 40354073)
16. Elbim C, Chollet-Martin S, Bailly S, Hakim J, Gougerot-Pocidalo MA: Priming of polymorphonuclear neutrophils (PMN) by tumor necrosis factor-in whole blood: identification of two PMN subpopulations in response to formyl-peptides. Blood 1993; 82: 633-640. (Pubitemid 23206132)
17. Wlodkowic D, Skommer J, Pelkonen J: Towards an understanding of apoptosis detection by SYTO dyes. Cytometry A 2007; 71A: 61-72. (Pubitemid 46238934)
18. Wymann MP, Kernen P, Bengtsson T, Andersson T, Baggiolini M, Deranleau DA: Corresponding oscillations in neutrophil shape and filamentous actin content. J Biol Chem 1990; 265: 619-622.
19. Powner DJ, Pettitt TR, Anderson R, Nash GB, Wakelam MJ: Stable adhesion and migration of human neutrophils requires phospholipase D-mediated activation of the integrin CD11b/CD18. Mol Immunol 2007; 44: 3211-3221. (Pubitemid 46610503)
20. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290:C917-C924.
21. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376. (Pubitemid 19106873)
22. Touré F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P: Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 2008; 416: 255-261.
23. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, Bianchi ME, Manfredi AA: HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5: 825-830. (Pubitemid 39199174)
24. Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR: Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 1994; 93: 499-508. (Pubitemid 24072788)
25. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB: Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102: 14729-14734. (Pubitemid 41457124)
26. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M: Annexin 1 and its bioactive peptide inhibit neutrophil-endoth elium interactions under flow: indication of distinct receptor involvement. Blood 2006; 107: 2123-2130. (Pubitemid 43289398)
27. Bournazou I, Pound JD, Duffin R, Bournazos S, Melville LA, Brown SB, Rossi AG, Gregory CD: Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest 2009; 119: 20-32.
28. Kokkola R, Li J, Sundberg E, Aveberger AC, Pamblad K, Yang H, Tracey KJ, Andersson U, Harris HE: Successful treatment of collageninduced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003; 48: 2052-2058. (Pubitemid 36828701)
29. Rowe SM, Jackson PL, Liu G, Hardison M, Livraghi A, Solomon GM, McQuaid DB, Noerager BD, Gaggar A, Clancy JP, O'Neal W, Sorscher EJ, Abraham E, Blalock JE: Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 2008; 178: 822-831.
30. Elbim C, Bailly S, Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA: Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infection and Immunity 1994; 62: 2195-2201. (Pubitemid 24157042)
31. Fan J, Malik AB: Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med 2003; 9: 315-321. (Pubitemid 36362787)
32. Knall C, Worthen GS, Johnson GL: Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 1997; 94: 3052-3057.
33. Oppermann M, Mack M, Proudfoot AEI, Olbrich H: Differential effects of CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxy terminus. J Biol Chem 1999; 274: 8875-8885. (Pubitemid 29164688)
34. Peregrin S, Jurado-Pueyo M, Campos PM, Sanz-Moreno V, Ruiz-Gomez A, Crespo P, Mayor F, Murga C: Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol 2006; 16: 2042-2047. (Pubitemid 44604449)
35. Tatsukawa T, Chimura T, Miyakawa H, Yamaguchi K: Involvement of basal protein kinase C and extracellular signal-regulated kinase 1/2 activities in constitutive internalization of AMPA receptors in cerebral Purkinje cells. J Neurosci 2006; 26: 4820-4825. (Pubitemid 44315322)
36. Wolff M, Kredel WM, Haasen D, Wiedenmann J, Nienhaus GU, Kistler B, Oswald F, Heilker R: High content screening of CXCR2-dependent signalling pathways. Comb Chem High Throughput Screen 2010; 13: 3-15.
37. Chen GY, Tang J, Zheng P, Liu Y: CD24 and Siglec-10 selectively repress tissue damageinduced immune responses. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009; 323: 1722-1725.
38. Landsman D, Bustin MA: Signature for the HMG-1 box DNA-binding proteins. Bioassays 1993; 15: 539-546.
39. Yuan H, Jin X, Sun J, Li F, Feng Q, Zhang C, Cao Y, Wang Y: Protective effect of HMGB1 A box on organ injury of acute pancreatitis in mice . Pancreas 2009; 38: 143-148.
40. Muhammad S, Barakat W, Stroyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M: The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008; 28: 12023-12120.
41. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya S, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbäurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008; 117: 3216-3226.
42. Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, Tan Z, Fang M, Rui L, Chen D, Wang S, Zheng X, Wang CY, Gong F: Extracellular HMGB1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007; 4: 799-808. (Pubitemid 46481209)
43. Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL: Protective effect of antagonist of highmobility group box 1 on lipopolysaccharideinduced acute lung injury in mice. Scand J Immunol 2009; 69: 29-35.